510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K781225Substantially Equivalent

Globulin Test, Human Thyroxine Binding

Hyland Therapeutic Div., Travenol Laboratories, Mchenry IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K781225 is the FDA 510(k) clearance record for GLOBULIN TEST, HUMAN THYROXINE BINDING, a class II device, cleared for Hyland Therapeutic Div., Travenol Laboratories on under FDA product code CEE (Radioimmunoassay, Thyroxine-Binding Globulin). FDA records list 44 510(k) clearances for Hyland Therapeutic Div., Travenol Laboratories, from to . As of , FDA records show no recalls naming K781225.

Clearance record

Decision date
Received
(44 days to decision)
Product code
CEE Radioimmunoassay, Thyroxine-Binding Globulin
Regulation
21 CFR 862.1685
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Hyland Therapeutic Div., Travenol Laboratories 803 N. Front St. Suite 3, Mchenry IL
Third party review
No

Clearances, product code CEE

Trailing 12 months

FDA records hold no clearances under product code CEE in the trailing twelve months.

FDA records show no clearances under product code CEE in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CEE, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260